SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention -NEJM editorial
From the Editorial ‘We are publishing today in the Journal the results of a phase 3, double-blind, randomized, controlled trial of
Read moreFrom the Editorial ‘We are publishing today in the Journal the results of a phase 3, double-blind, randomized, controlled trial of
Read moreThe rapid test kits most widely used in UK universities, schools, and care homes detect just 48.89% of covid-19 infections
Read moreA living WHO guideline on drugs for covid-19 Clinical question What is the role of drug interventions in the treatment of
Read moreWhat is the best mask for protection against Covid-19? Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective
Read moreThe US government is investing in rapid development of vaccines against coronavirus disease 2019 (COVID-19), several relying on new technologies.1
Read moreVitamin D and Covid-19: the current evidence Vitamin D has been associated with many disease states from osteoporosis, cancer, diabetes,
Read moreCovid-19: politicisation, “corruption,” and suppression of science
Read moreTo health care professionals everywhere: these are unprecedented times. There’s no roadmap. We’re facing conversations that we never expected—or wanted—to
Read moreObjective To compare the effects of treatments for coronavirus disease 2019 Design Living systematic review and network meta-analysis. Data sources US Centers
Read more